iPHONE 12

India's Jubilant Signs Licensing Deal For US Pharma Firm's COVID-19 Drug

India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries,...

Share:

No comments:

Post a Comment

amazon

Back to Top

Popular Posts

Blog Archive

Recent Posts